343 related articles for article (PubMed ID: 20688574)
1. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial.
VITATOPS Trial Study Group
Lancet Neurol; 2010 Sep; 9(9):855-65. PubMed ID: 20688574
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial.
Hankey GJ; Eikelboom JW; Yi Q; Lees KR; Chen C; Xavier D; Navarro JC; Ranawaka UK; Uddin W; Ricci S; Gommans J; Schmidt R;
Lancet Neurol; 2012 Jun; 11(6):512-20. PubMed ID: 22554931
[TBL] [Abstract][Full Text] [Related]
3. VITATOPS, the VITAmins TO prevent stroke trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444).
; Hankey GJ; Algra A; Chen C; Wong MC; Cheung R; Wong L; Divjak I; Ferro J; de Freitas G; Gommans J; Groppa S; Hill M; Spence D; Lees K; Lisheng L; Navarro J; Ranawaka U; Ricci S; Schmidt R; Slivka A; Tan K; Tsiskaridze A; Uddin W; Vanhooren G; Xavier D; Armitage J; Hobbs M; Le M; Sudlow C; Wheatley K; Yi Q; Bulder M; Eikelboom JW; Hankey GJ; Ho WK; Jamrozik K; Klijn K; Koedam E; Langton P; Nijboer E; Tuch P; Pizzi J; Tang M; Antenucci M; Chew Y; Chinnery D; Cockayne C; Loh K; McMullin L; Smith F; Schmidt R; Chen C; Wong MC; de Freitas G; Hankey GJ; Loh K; Song S
Int J Stroke; 2007 May; 2(2):144-50. PubMed ID: 18705976
[TBL] [Abstract][Full Text] [Related]
4. Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis.
Hankey GJ; Ford AH; Yi Q; Eikelboom JW; Lees KR; Chen C; Xavier D; Navarro JC; Ranawaka UK; Uddin W; Ricci S; Gommans J; Schmidt R; Almeida OP; van Bockxmeer FM;
Stroke; 2013 Aug; 44(8):2232-9. PubMed ID: 23765945
[TBL] [Abstract][Full Text] [Related]
5. B vitamins and magnetic resonance imaging-detected ischemic brain lesions in patients with recent transient ischemic attack or stroke: the VITAmins TO Prevent Stroke (VITATOPS) MRI-substudy.
Cavalieri M; Schmidt R; Chen C; Mok V; de Freitas GR; Song S; Yi Q; Ropele S; Grazer A; Homayoon N; Enzinger C; Loh K; Wong KS; Wong A; Xiong Y; Chang HM; Wong MC; Fazekas F; Eikelboom JW; Hankey GJ;
Stroke; 2012 Dec; 43(12):3266-70. PubMed ID: 23093615
[TBL] [Abstract][Full Text] [Related]
6. The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial.
Gommans J; Yi Q; Eikelboom JW; Hankey GJ; Chen C; Rodgers H;
BMC Geriatr; 2013 Sep; 13():88. PubMed ID: 24004645
[TBL] [Abstract][Full Text] [Related]
7. The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.
VITATOPS Trial Study Group
Cerebrovasc Dis; 2002; 13(2):120-6. PubMed ID: 11867886
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial.
Sharma M; Molina CA; Toyoda K; Bereczki D; Bangdiwala SI; Kasner SE; Lutsep HL; Tsivgoulis G; Ntaios G; Czlonkowska A; Shuaib A; Amarenco P; Endres M; Yoon BW; Tanne D; Toni D; Yperzeele L; von Weitzel-Mudersbach P; Sampaio Silva G; Avezum A; Dawson J; Strbian D; Tatlisumak T; Eckstein J; Ameriso SF; Weber JR; Sandset EC; Goar Pogosova N; Lavados PM; Arauz A; Gailani D; Diener HC; Bernstein RA; Cordonnier C; Kahl A; Abelian G; Donovan M; Pachai C; Li D; Hankey GJ
Lancet Neurol; 2024 Jan; 23(1):46-59. PubMed ID: 38101902
[TBL] [Abstract][Full Text] [Related]
9. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.
Galan P; Kesse-Guyot E; Czernichow S; Briancon S; Blacher J; Hercberg S;
BMJ; 2010 Nov; 341():c6273. PubMed ID: 21115589
[TBL] [Abstract][Full Text] [Related]
10. Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial.
Hankey GJ; Eikelboom JW; Yi Q; Lees KR; Chen C; Xavier D; Navarro JC; Ranawaka UK; Uddin W; Ricci S; Gommans J; Schmidt R;
Stroke; 2012 Jun; 43(6):1572-7. PubMed ID: 22474057
[TBL] [Abstract][Full Text] [Related]
11. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of GABA
Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
[TBL] [Abstract][Full Text] [Related]
13. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
Albert CM; Cook NR; Gaziano JM; Zaharris E; MacFadyen J; Danielson E; Buring JE; Manson JE
JAMA; 2008 May; 299(17):2027-36. PubMed ID: 18460663
[TBL] [Abstract][Full Text] [Related]
14. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N
Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153
[TBL] [Abstract][Full Text] [Related]
15. The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.
Potter K; Hankey GJ; Green DJ; Eikelboom J; Jamrozik K; Arnolda LF
BMC Cardiovasc Disord; 2008 Sep; 8():24. PubMed ID: 18803866
[TBL] [Abstract][Full Text] [Related]
16. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.
; Armitage JM; Bowman L; Clarke RJ; Wallendszus K; Bulbulia R; Rahimi K; Haynes R; Parish S; Sleight P; Peto R; Collins R
JAMA; 2010 Jun; 303(24):2486-94. PubMed ID: 20571015
[TBL] [Abstract][Full Text] [Related]
17. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
Toole JF; Malinow MR; Chambless LE; Spence JD; Pettigrew LC; Howard VJ; Sides EG; Wang CH; Stampfer M
JAMA; 2004 Feb; 291(5):565-75. PubMed ID: 14762035
[TBL] [Abstract][Full Text] [Related]
18. The China Stroke Secondary Prevention Trial (CSSPT) protocol: a double-blinded, randomized, controlled trial of combined folic acid and B vitamins for secondary prevention of stroke.
Liu X; Shi M; Xia F; Han J; Liu Z; Wang B; Yang F; Li L; Wu S; Wang L; Liu N; Lv Y; Zhao G
Int J Stroke; 2015 Feb; 10(2):264-8. PubMed ID: 23490255
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
Lancet Neurol; 2017 Apr; 16(4):301-310. PubMed ID: 28238711
[TBL] [Abstract][Full Text] [Related]
20. Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial.
Loeb M; Roy A; Dokainish H; Dans A; Palileo-Villanueva LM; Karaye K; Zhu J; Liang Y; Goma F; Damasceno A; Alhabib KF; Yonga G; Mondo C; Almahmeed W; Al Mulla A; Thanabalan V; Rao-Melacini P; Grinvalds A; McCready T; Bangdiwala SI; Yusuf S;
Lancet Glob Health; 2022 Dec; 10(12):e1835-e1844. PubMed ID: 36400089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
